| Name | COX-2-IN-20 |
|---|
| Description | COX-2-IN-20 (Compound 5d) is a selective and orally active COX-2 inhibitor with an IC50 of 17.9 nM. COX-2-IN-20 shows anti-inflammatory activity[1]. |
|---|---|
| Related Catalog | |
| Target |
COX-2:17.9 nM (IC50) COX-1:19.3 μM (IC50) |
| In Vitro | COX-2-IN-20 (Compound 5d) shows potential anti-inflammatory activity on NO inhibition in LPS-induced RAW 264.7 cell with an IC50 of 2.87 μM[1]. |
| In Vivo | COX-2-IN-20 (Compound 5d) (5 mg/kg) exhibits better in vivo anti-inflammation and gastric protection than 10 mg/kg Indomethacin[1]. |
| References |
| Molecular Formula | C11H9ClFN3O2 |
|---|---|
| Molecular Weight | 269.66 |